Asia Pacific Transfection Reagents And Equipment Market Research Report - Segmented By Product, Method, Application, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts 2024 to 2029

Updated On: January, 2024
ID: 3089
Pages: 178

Asia Pacific Transfection Reagents and Equipment Market Size & Growth (2022 to 2027):

As per the research report, the size of the Asia-Pacific Transfection Reagents and Equipment market size was valued at USD 223.22 million in 2022. It is expected to grow at a CAGR of 8% to reach USD 327.98 million by 2027 during the forecast period 2022 to 2027.

Reagents and instruments are divided into two categories in the Asia-Pacific transfection reagents and equipment market. One of the most important factors is that the transfection reagents and equipment market has evolved through time to fulfil the needs of researchers and biotechnology and pharmaceutical firms.

Market developments have resulted in the development of more efficient high-throughput large-scale transfection devices and reagents. Advanced methods enable efficient quantitative and qualitative transfection in a wide range of cells, including those that are difficult to transfect.

Another important feature is the expertise in consulting projects and market research in high-growth areas, cutting-edge technologies, and novel applications.

The technology in Transfection reagents and equipment aids cells in cancer cell mutation, protein metabolism by influencing nuclear genes, and gene therapy control. Transfection is a crucial tool in gene function and gene expression regulation research.

Basic cellular research, drug discovery, and target validation all benefit from it. The market for transfection reagents and equipment is fueled by protein production, an ageing population, and an increase in cancer prevalence. The market for transfection reagents and equipment has been boosted by a number of government initiatives.

However, the high cost of transfection reagents and equipment, as well as risk issues during reagent insertion and the cytotoxic effect associated with transfection technology, are limiting the market for transfection reagents and equipment.

This research report on the APAC Transfection Reagents and Equipment Market has been segmented and sub-segmented into the following categories:

By Product:

  • Reagents
  • Instruments     

By Method:

  • Biochemical
  • Calcium Phosphate
  • Physical
  • Viral  

By Application:

  • Biomedical Research
  • Protein Production
  • Therapeutic Delivery           

By End User:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies  

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific is one of the fastest growing regions in terms of transfection reagents and equipment in the world due to rising occurrence of various malignancies such as cervical cancer, breast cancer, colon cancer, and prostate cancer.

Furthermore, increased demand for proteomics and genomics technologies, as well as proactive government activities aimed at preventing disease, have aided the growth of the transfection reagents and equipment market in this area. The need for transfection reagents and equipment is influenced by the developing trend of targeted drug delivery, nanomedicine in diagnostics, clinical trials, and drug development investigations.          

In the transfection reagents and equipment industry, Asia-Pacific is still considered an emerging market in its early stages. Outsourcing of clinical trials to Asian nations such as India, Japan, and China by the bulk of drug research corporations is one of the primary regional drivers impacting the rise of transfection reagent and equipment.

Furthermore, the advancement of in transfection technology, the demand for protein therapies, the growth of healthcare infrastructure in growing countries such as India and China, and rising demand from application markets are also factors to consider. Because of the expanding medical infrastructure, high disposable income, and rising prevalence, there is a huge potential for expansion.

Reagents of this type can be employed in a variety of ways, including chemical, physical, and biological methods. Technological developments in transfection, an increase in R&D spending and research activities by biotech companies, and a rise in demand for synthetic genes are all important regional factors that are stifling industry expansion.


The Top companies leading in the APAC Transfection Reagents and Equipment Market profiled in the report are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample